Trial · NCT04089566
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Part A: 28/28 mg Nusinersen | 0 | 6 |
| Total, all-cause mortality | Part B: Infantile-Onset SMA: 12/12 mg Nusinersen | 6 | 25 |
| Total, all-cause mortality | Part B: Infantile-Onset SMA: 50/28 mg Nusinersen | 10 | 50 |
| Total, all-cause mortality | Part B: Later-Onset SMA: 12/12 mg Nusinersen | 0 | 8 |
| Total, all-cause mortality | Part B: Later-Onset SMA: 50/28 mg Nusinersen | 0 | 16 |
| Total, all-cause mortality | Part C: 50/28 mg Nusinersen | 0 | 40 |
| Total, other adverse events | Part A: 28/28 mg Nusinersen | 4 | 6 |
| Total, other adverse events | Part B: Infantile-Onset SMA: 12/12 mg Nusinersen | 19 | 25 |
| Total, other adverse events | Part B: Infantile-Onset SMA: 50/28 mg Nusinersen | 37 | 50 |
| Total, other adverse events | Part B: Later-Onset SMA: 12/12 mg Nusinersen | 7 | 8 |
| Total, other adverse events | Part B: Later-Onset SMA: 50/28 mg Nusinersen | 14 | 16 |
| Total, other adverse events | Part C: 50/28 mg Nusinersen | 36 | 40 |
| Total, serious adverse events | Part A: 28/28 mg Nusinersen | 1 | 6 |
| Total, serious adverse events | Part B: Infantile-Onset SMA: 12/12 mg Nusinersen | 18 | 25 |
| Total, serious adverse events | Part B: Infantile-Onset SMA: 50/28 mg Nusinersen | 30 | 50 |
| Total, serious adverse events | Part B: Later-Onset SMA: 12/12 mg Nusinersen | 4 | 8 |
| Total, serious adverse events | Part B: Later-Onset SMA: 50/28 mg Nusinersen | 2 | 16 |
| Total, serious adverse events | Part C: 50/28 mg Nusinersen | 6 | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04089566/event-totals